Stotles logo
Openclosing

UCLH-6630 - LECANEMAB HOMECARE SERVICE

Published

Description

Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only.

Timeline

Publish date

a month ago

Close date

in 1 day

Buyer information

Explore contracts and tenders relating to University College London Hospitals NHS Foundation Trust

Go to buyer profile
To save this opportunity, sign up to Stotles for free.
Save in app
  • Looking glass on top of a file iconTender tracking

    Access a feed of government opportunities tailored to you, in one view. Receive email alerts and integrate with your CRM to stay up-to-date.

  • ID card iconProactive prospecting

    Get ahead of competitors by reaching out to key decision-makers within buying organisations directly.

  • Open folder icon360° account briefings

    Create in-depth briefings on buyer organisations based on their historical & upcoming procurement activity.

  • Teamwork iconCollaboration tools

    Streamline sales workflows with team collaboration and communication features, and integrate with your favourite sales tools.

Stop chasing tenders, start getting ahead.

Create your free feed

Explore other contracts published by University College London Hospitals NHS Foundation Trust

Explore more open tenders, recent contract awards and upcoming contract expiries published by University College London Hospitals NHS Foundation Trust.

Explore more suppliers to University College London Hospitals NHS Foundation Trust

Sign up